Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain
Por:
Calvet, X, Panes, J, Gallardo-Escudero, J, de la Cuadra-Grande, A, Bartolome, E, Marin, L, de la Portilla, F, Navarro-Correal, E, Gutierrez, A, Nos, P, Serrano, R, Casado, MA and Barreiro-de Acosta, M
Publicada:
23 nov 2022
Ahead of Print:
1 may 2022
Resumen:
Background and Aims Management of inflammatory bowel disease [IBD] is complex and IBD Comprehensive Care Units [ICCUs] facilitate the delivery of quality care to IBD patients. The objective of this study was to update the existing set of quality indicators [QIs] for ICCUs, based on a nationwide quality certification programme carried out in Spain, from a multi-stakeholder perspective and using multicriteria decision analysis [MCDA] methodology. Methods An MCDA comprising three different phases was conducted. In phase 1, a systematic literature review was performed, and after validation by a scientific committee comprising 11 experts, a preliminary set of QIs was developed. In phase 2, a larger group of 49 experts determined the relevance and relative importance of each QI by prioritising and weighing the preliminary set. Finally in phase 3, the scientific committee reviewed the results and made a final selection via a deliberative process. Results The final set comprised 67 QIs, classified as Structure [23 QIs], Process [35 QIs] and Outcome [9 QIs], which were ranked according to their relative importance. Multidisciplinary management was the most important requirement in ICCUs, followed by continuity of care, standardisation of clinical care and, especially, the incorporation of patients' reported outcomes. Conclusions This updated set of QIs comprises a weighted and prioritised set of items that represent the essential minimum of criteria for ensuring appropriate quality of care in the management of IBD patients.
Filiaciones:
Calvet, X:
Corp Sanitaria Univ Parc Tauli, Serv Aparell Digestiu, Barcelona, Spain
Inst Salud Carlos III, CIBEREHD, Madrid, Spain
Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
Panes, J:
Inst Salud Carlos III, CIBEREHD, Madrid, Spain
Hosp Clin Barcelona, Gastroenterol Dept, IDIBAPS, Barcelona, Spain
Gallardo-Escudero, J:
Pharmacoecon & Outcomes Res Iberia PORIB, Hlth Econ Dept, Madrid, Spain
de la Cuadra-Grande, A:
Pharmacoecon & Outcomes Res Iberia PORIB, Hlth Econ Dept, Madrid, Spain
Bartolome, E:
Soc Espanola Calidad Asistencial, Oviedo, Spain
:
Hosp Univ Germans Trias I Pujol, Gastroenterol & Hepatol Dept, Barcelona, Spain
de la Portilla, F:
Hosp Univ Virgen del Rocio, Gen Surg & Digest Syst Clin Management Unit, Seville, Spain
Navarro-Correal, E:
Vall dHebron Hosp Univ, Crohn Colitis Care Unit, Barcelona, Spain
Gutierrez, A:
Inst Salud Carlos III, CIBEREHD, Madrid, Spain
Hosp Gen Alicante, Gastroenterol Dept, Alicante, Spain
Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain
Nos, P:
Hosp Univ La Fe, Gastroenterol Unit, Valencia, Spain
Serrano, R:
Confederac Asociac Crohn & Colitis Ulcerosa, Madrid, Spain
Casado, MA:
Pharmacoecon & Outcomes Res Iberia PORIB, Hlth Econ Dept, Madrid, Spain
Barreiro-de Acosta, M:
Hosp Clin Univ Santiago de Compostela, Gastroenterol Dept, Santiago De Compostela, Spain
Green Published
|